These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6212203)

  • 1. Dose dependence of piperacillin pharmacokinetics.
    Bergan T; Williams JD
    Chemotherapy; 1982; 28(3):153-9. PubMed ID: 6212203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of piperacillin in subjects with various degrees of renal function.
    Welling PG; Craig WA; Bundtzen RW; Kwok FW; Gerber AU; Madsen PO
    Antimicrob Agents Chemother; 1983 Jun; 23(6):881-7. PubMed ID: 6225390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously administered piperacillin in preadolescent children.
    Thirumoorthi MC; Asmar BI; Buckley JA; Bollinger RO; Kauffman RE; Dajani AS
    J Pediatr; 1983 Jun; 102(6):941-6. PubMed ID: 6222169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.
    Tjandramaga TB; Mullie A; Verbesselt R; De Schepper PJ; Verbist L
    Antimicrob Agents Chemother; 1978 Dec; 14(6):829-37. PubMed ID: 742871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic studies of piperacillin after 4 g or 8 g intravenous injection in human healthy volunteers].
    Nakagawa K; Yasuda T; Nakajima Y; Watanabe Y; Noguchi M; Suzuki T
    Jpn J Antibiot; 1982 Dec; 35(12):2797-804. PubMed ID: 6222208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of piperacillin dose on elimination kinetics in renal impairment.
    Aronoff GR; Sloan RS; Brier ME; Luft FC
    Eur J Clin Pharmacol; 1983; 24(4):543-7. PubMed ID: 6222908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.
    Meyers BR; Hirschman SZ; Strougo L; Srulevitch E
    Antimicrob Agents Chemother; 1980 Apr; 17(4):608-11. PubMed ID: 6446878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of defibrotide in healthy volunteers.
    Noseda G; Fragiacomo C; Ferrari D
    Haemostasis; 1986; 16 Suppl 1():26-30. PubMed ID: 3754833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin pharmacokinetics in pediatric patients.
    Wilson CB; Koup JR; Opheim KE; Adelman LA; Levy J; Stull TL; Clausen C; Smith AL
    Antimicrob Agents Chemother; 1982 Sep; 22(3):442-7. PubMed ID: 6215893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temocillin in volunteers.
    Hampel B; Feike M; Koeppe P; Lode H
    Drugs; 1985; 29 Suppl 5():99-102. PubMed ID: 4029032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.
    Francke EL; Appel GB; Neu HC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers.
    Tartaglione TA; Nye L; Vishniavsky N; Poynor W; Polk RE
    Clin Pharm; 1986 Nov; 5(11):911-6. PubMed ID: 3780161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin kinetics.
    Batra VK; Morrison JA; Lasseter KC; Joy VA
    Clin Pharmacol Ther; 1979 Jul; 26(1):41-53. PubMed ID: 445961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin pharmacokinetics in subjects with chronic renal failure.
    Thompson MI; Russo ME; Matsen JM; Atkin-Thor E
    Antimicrob Agents Chemother; 1981 Mar; 19(3):450-3. PubMed ID: 6454382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.